Stocks to sell

Is there still hope for Ocugen (NASDAQ:OCGN)? Or are the OCGN stock bulls just delusional? In my view, you can count on the latter. Any way you slice it, this biotech company has little chance of generating big profits — or even big sales — from its Covaxin Covid-19 vaccine candidate. Source: Shutterstock As you

Rocket Companies (NYSE:RKT) should present investors with a relatively simple proposition. If you believe that the housing market will remain robust, you’re a buyer of RKT stock. If you believe there will be a normalization or pull back, then you’re sitting out. Source: Lori Butcher / Shutterstock.com    So far in 2021, it looks like the latter is occurring. Rocket Companies is the parent

After Reddit’s subgroup, r/WallStreetBets, sent AMC Entertainment  (NYSE:AMC) flying, the shares have proven to have staying power. AMC stock has hovered near $60 for nearly all of June, and the stock is not too far from its 52-week high. Source: Helen89 / Shutterstock.com AMC has a history of selling shares and raising debt because its

AMC Entertainment (NYSE:AMC) stock has had a mind-boggling run, but that doesn’t mean this meme stock favorite can hold onto its gains. Source: rblfmr/Shutterstock.com AMC stock has rallied 176% in the past month and now sits at around $58 a share. Year-to-date, AMC stock has gained more than 2,590%. On the first trading day of 2021,

Sundial Growers (NASDAQ:SNDL) stock is up 94.9% year-to-date, but there is cause for concern. Source: shutterstock.com/Tunatura SNDL stock has lost 36.8% in the last month. So it seems that the cannabis producer’s Reddit-induced rally is done and dusted. Welcome to the world of Reddit investing, where weakness can become a source of strength. If the

With the power of meme stock fans demonstrably weakening and Clover Health (NASDAQ:CLOV) continuing to face an SEC investigation, the longer-term outlook of CLOV stock remains negative. Source: Shutterstock As a result, I urge investors to sell the company’s shares. Clover Health has become a favorite of the social media-oriented investors, i.e. the meme stock

ContextLogic (NASDAQ:WISH) stock went public last December. After a brief pop, the share price fell to single digits in May. Source: sdx15 / Shutterstock.com It fell because ContextLogic loses money. Its first quarter report showed a loss of $128 million, 21 cents per share, on revenue of $772 million. Losses from operations, $126 million, grew

Workhorse (NASDAQ:WKHS) reported very weak first-quarter results and  appears to have no viable, strong, upcoming, positive catalysts. WKHS stock is in trouble. Source: Shutterstock The EV maker’s inability to win any major deals or recruit any impressive partners so far, its apparent failure to cash in on opportunities with the U.S. Post Office and UPS

I’m sure many investors in AMC Entertainment (NYSE:AMC) have stopped reading this article just based on the headline. And others are ready to tell me I don’t get it. So let me be clear. When it comes to AMC stock, I understand your point. I just disagree with it.   Source: QualityHD / Shutterstock.com In 2021, AMC stock is at its

Health insurance company Clover Health (NASDAQ:CLOV) went public via the SPAC route in January, and since then, its stock has been on a wild ride. CLOV stock became the latest target of the Reddit retail trading crowd, causing Clover’s share  price to reach new highs. Source: Shutterstock Unfortunately, the stock is now overvalued, and Clover’s

Shares of once-famed gadget maker BlackBerry (NYSE:BB) were brought back from the dead by the meme stock investors this year. BB stock is appreciating heavy volume again as it appears to be caught up in the retail trading frenzy. One-month returns from the stock are at a staggering 47%. However, the momentum should be short-lived

The outlook of Carnival Corporation (NYSE:CCL) stock has improved in recent weeks, but given the cruise operator’s extremely high debt load and the great amount of uncertainty it continues to face, I still urge investors to sell their shares. Source: Ruth Peterkin / Shutterstock.com In addition to its highly elevated debt load, Carnival must deal

The party’s over once again for Clover Health (NASDAQ:CLOV) stock. A few months back, the insurtech company, and former SPAC (special purpose acquisition company), was a popular health care-related “story stock.” Source: Shutterstock News of a Department of Justice (DOJ) investigation fueled a big change in investor’s opinions about it. But starting in the spring,

Lordstown Motors (NASDAQ:RIDE) stock is becoming a cautionary tale for many investors in electric vehicle (EV) stocks. Source: Postmodern Studio / Shutterstock.com RIDE stock is down almost 50% in 2021. And that was the case before the company announced that its “backlog” of pre-orders do not represent binding commitment.   That announcement came on the heels of top

Bionano Genomics (NASDAQ:BNGO) stock might appear interesting at first blush. After all, the company has developed an optical DNA mapping instrument called Saphyr. It is a high throughput system – which looks like a printer from the outside – that allows genome variations to be rapidly identified.  Source: Connect world / Shutterstock.com However, upon taking

Clover Health (NASDAQ:CLOV) stock is up 57% in the last month. The price action highlights the uncertainty of investing in celebrity SPAC (special purpose acquisition company) plays. Source: Shutterstock Bit of background here. Venture capitalist and resident SPAC king Chamath Palihapitiya helped Clover, which sells Medicare-backed insurance plans, to go public through a $3.7 billion deal

I’ve been wrong twice about DraftKings (NASDAQ:DKNG) stock. I may be again. In June 2020, six months after DraftKings came public, I warned people to look out below. At the time the stock was at $42/share. It has since traded for as much as $72/share. In January 2021 I suggested there was still time to

MicroVision is still up for sale, just like the CEO said it was and the latest 10-Q report indicates. Unfortunately, there are still no buyers. Source: Shutterstock For some reason, the market thinks a deal will happen when the stock is at a market value of $3.41 billion. Allow me to provide an evidently-needed reality

Canoo (NASDAQ:GOEV) released its earnings on May 17 and made some concerning statements. Expect GOEV stock to drive lower. Source: Shutterstock For starters, the company is no longer going to use a contract manufacturer. It also expects to take until 2023 before electric vehicle (EV) deliveries and revenue begin to flow into the company. More troubling

Since the beginning of the year, shares of Cyprus-based shipping company Castor Maritime (NASDAQ:CTRM) stock are up by more than 80%. Source: Pavel Kapysh / Shutterstock.com As stated in its filings with the SEC back in April, its recent stock increases were “significantly inconsistent” with its performance. It continues to expand its fleet aggressively, putting

While it may seem like “meme-stock mania” is over, several of these names are still up triple digits this year. In fact, much-maligned meme stocks are not losing steam as the more than 10 million members of Reddit’s r/WallStreetBets (WSB) community continue to push shares upward. However — as is the case with most companies

Lordstown Motors (NASDAQ:RIDE) stock, the electric car start-up, took a hard fall but then rose again on a management re-shuffle. Source: Postmodern Studio / Shutterstock.com The company admitted misstatements in demand for its Endurance pick-up. Then it accepted the resignations of CEO Steve Burns and CFO Julio Rodriguez. Becky Roof, an accountant who has been

While Senseonics (NYSE:SENS) stock has a great deal of potential, the shares currently have a fairly high valuation. Source: Minerva Studio / Shutterstock.com Moreover, in the short-term and medium-term, SENS stock looks poised to fall significantly. Senseonics has developed Eversense, a 90-day continuous glucose monitoring (CGM) system. According to the company, the device provides continuous

With Zomedica’s  (NYSE:ZOM) new Truforma diagnostic tool possibly facing a great deal of entrenched competition, the outlook of ZOM stock is, at best, difficult to determine. Meanwhile, the shares have a very high valuation. Source: didesign021 / Shutterstock.com A diagnostic product meant to be used by veterinarians, Truforma measures the amount of T4 and TSH

When I last wrote about Vaxart (NASDAQ:VXRT) last month I indicated that I felt that the biotech company was not worth more than about $1 per share. As of June 16, VXRT stock was at $7.67, or $1.00 higher than when I wrote about it on May 14 at $6.61. Source: Photo courtesy of Vaxart,

There’s been plenty of talk about GameStop (NYSE:GME) stock going to the moon in 2021. At the same time, there’s been plenty of people pounding the table that the stock is overvalued. Source: Northfoto / Shutterstock.com For sure, GME stock is overvalued compared to where it was just a year ago. The stock is up

Fisker (NYSE:FSR) detailed ongoing operating and capital spending plans in its latest Q1 earnings release on May 17. A capital raise looks likely for the electric vehicle (EV) car maker, and likely to wreak havoc on FSR stock, at least until investors have visibility on when, exactly, they can expect Fisker to start producing free

For some strange reason, Reddit’s WallStreetBets embraced the short-squeeze of AMC Entertainment Holdings (NYSE:AMC). While its business is on the cusp of recovering, its earnings will not get anywhere near a level that justifies its valuation. Its market capitalization, which exceeded that of GameStop (NYSE:GME) at the end of last week, is most puzzling. For

This latest round of meme-stock mania in Gamestop (NYSE:GME) may be ending fast. GME stock — which began trading divorced of its fundamentals at the start of the year — has fallen around 30% since its Jun. 9 close. Source: Shutterstock / mundissima The renewed enthusiasm in former favorites of Reddit’s r/WallStreetBets subreddit may be

QuantumScape (NYSE:QS) went from a hot special purpose acquisition company (SPAC) to damaged goods in record time. Back in December, QS stock traded for $130 per share. Just six months later, QuantumScape has lost a crushing 75% of its value. Source: Michael Vi / Shutterstock.com Why did electric vehicle (EV) battery maker QuantumScape power down